CD44 expression in patients with combined hepatocellular cholangiocarcinoma

PURPOSE: Combined hepatocellular cholangiocarcinoma (ChC) is a rare type of primary liver cancer, which is thought to have a poorer prognosis than hepatocellular carcinoma (HCC). Cancer stem cells are associated with tumorigenesis, tumor progression, recurrence, metastasis, and poor prognosis in sev...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ann Surg Treat Res
Hlavní autoři: Kim, Ryounggo, Kim, Sang Bum, Cho, Eung-Ho, Park, Sun Hoo, Park, Sung Bae, Hong, Seong Kweon, Chae, Gibong
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Surgical Society 2015
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481034/
https://ncbi.nlm.nih.gov/pubmed/26131439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/astr.2015.89.1.9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky